We came across a bullish thesis on Medpace Holdings, Inc. on FluentInQuality’s Substack. In this article, we will summarize the bulls’ thesis on MEDP. Medpace Holdings, Inc.'s share was trading at $530.30 as of October 6th. MEDP’s trailing and forward P/E were 39.83 and 36.23 respectively according to Yahoo Finance.
[caption id="attachment_597891" align="aligncenter" width="750"]Medpace is a global, full-service clinical research organization (CRO) serving biotech, pharmaceutical, and medical device companies, distinguished by its trusted...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.